Once confined to speculative and science fiction, miniature micro- or nanobots targeting pathogens or conditions directly have now become reality in research labs worldwide. But to enter clinical trials, scientists still have to overcome two major hurdles – visualising the tiny machines inside the body, and preventing a potential immune response.
Cell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer and Executive Director.
Antiviral drug discovery company ReViral announced the successful completion of a of a US$55m Series B financing. The funding will go toward clinical studies for its respiratory tract infection treatment.
The global market value of biodegradable plastics has passed the US$1.1bn mark in 2018, a report by IHS Markit says. More than half of the demand comes from Western Europe, driven by increasing regulation.
Pascal Schmidt appointed CFO as Vienna based biotech firm Marinomedas of August 1 2018.